The world’s vaccines have experienced very rapid development, especially since the COVID-19 pandemic hit. Many countries are competing to develop, produce and distribute vaccines. Technological innovations, such as the use of mRNA platforms, have accelerated the vaccine research and development process. For example, Pfizer-BioNTech and Moderna have been pioneers in using mRNA technology to fight COVID-19, offering unprecedented speed and efficiency. However, behind this progress, there are serious global challenges. Unequal distribution of vaccines is a major issue. Low-income countries largely lack access to vaccines. According to data from the World Health Organization (WHO), around 80% of the total COVID-19 vaccine doses were given to high-income countries, while poor countries had difficulty getting adequate supplies. This has resulted in detrimental inequalities, hampering global efforts to control the pandemic. Another challenge that is no less significant is the emergence of new variants of the virus. Variants such as Delta and Omicron show the ability to evade immunity generated by previous infection or vaccination. Therefore, there is a need for ongoing research regarding the effectiveness of existing vaccines and the possibility of developing new, more effective vaccines. Apart from that, booster vaccination is also important to increase immunity, especially for vulnerable groups. The pandemic has also encouraged international collaboration in vaccine research and development. Initiatives such as COVAX aim to provide global and equitable access to vaccines. However, insufficient funding and protectionist policies of some countries limit the effectiveness of these initiatives. The availability of raw materials is also an obstacle, because many vaccine production requires special components that are difficult to obtain. Apart from distribution issues, other challenges include anti-vaccine protests taking place in several countries. Misinformation about vaccines on social media contributes to public distrust, hampering vaccination efforts. Good education and appropriate campaigns are very necessary to increase vaccine acceptance among the public. Apart from that, government regulations and policies that support vaccination also need to be strengthened to create a conducive climate. With technological advances and increasing global awareness, the world has the potential to overcome these challenges. Collaboration between governments, health institutions and the private sector is essential to ensure equitable access to vaccines and accelerate innovation in their development. Maintaining public confidence in vaccines is also the key to success in fighting this pandemic. Sustainability and preparedness for future pandemics depends on the results of this collaboration and the commitment of all parties to deliver effective global health solutions.